Niagen Bioscience (NAGE) Research & Development (2010 - 2026)

Niagen Bioscience (NAGE) has 17 years of Research & Development data on file, last reported at $1.5 million in Q1 2026.

• On a quarterly basis, Research & Development rose 17.73% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $6.6 million, a 64.26% decrease from a year earlier, with the FY2025 full-year figure at $6.3 million, down 78.52% from the prior year.
• Research & Development for Q1 2026 stood at $1.5 million, down from $1.7 million in the prior quarter.
• Over the last five years, Research & Development for NAGE reached as high as $24.8 million in Q4 2022 and fell as low as $1.2 million in Q1 2023.
• Historically, Research & Development has averaged $5.5 million across 5 years, with a median of $1.7 million in 2025.
• Across the five-year window, Research & Development soared 946.63% in 2022 and tumbled 85.52% in 2023, its largest moves.
• Year by year, Research & Development stood at $24.8 million in 2022, then retreated by 8.59% to $22.6 million in 2023, then slumped by 61.5% to $8.7 million in 2024, then slumped by 80.38% to $1.7 million in 2025, then dropped by 13.39% to $1.5 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $1.5 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.